Harbor Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Harbor Capital Advisors's LLY Position: Q1 2026 in Review
Harbor Capital Advisors reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $2.13M and leaving 10,250 shares worth $9.43M. The position accounts for 0.76% of the portfolio, ranked #18.
Harbor Capital Advisors first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $13.6M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Harbor Capital Advisors held 10,250 shares of Eli Lilly worth $9.43M as of Q1 2026.
- Harbor Capital Advisors sold 2,102 Eli Lilly shares in Q1 2026, an estimated $2.13M.
- Eli Lilly made up 0.76% of Harbor Capital Advisors's portfolio in Q1 2026, its #18 holding.
- Harbor Capital Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
- Harbor Capital Advisors's Eli Lilly position peaked at $13.6M in Q2 2024.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.